default author photo

Boris Hadaschik

University Hospital Essen - Department of Urology

SCHOLARLY PAPERS

3

DOWNLOADS

277

TOTAL CITATIONS

3

Scholarly Papers (3)

1.

Combined Mri-Targeted and Systematic Biopsy in Young Men (45-54 Years) Remains Necessary – Data from the Probase Trial

Number of pages: 20 Posted: 23 Jan 2025
Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf, German Cancer Research Center (DKFZ), Heinrich Heine University Dusseldorf, German Cancer Research Center (DKFZ), German Cancer Research Center (DKFZ), Technische Universität München (TUM), Technische Universität München (TUM), Technische Universität München (TUM), Hannover Medical School, Hannover Medical School, Technische Universität München (TUM) - Department of Diagnostic and Interventional Radiology, Technische Universität München (TUM) - Department of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover Medical School, German Cancer Research Center (DKFZ), Ruprecht Karls University, Heinrich Heine University Dusseldorf, German Cancer Research Center (DKFZ), University Hospital Essen - Department of Urology, Heinrich Heine University Dusseldorf, University of Bonn - University Hospital Bonn (UKB), Heinrich Heine University Dusseldorf, German Cancer Research Center (DKFZ), German Cancer Research Center (DKFZ) - Division of Clinical Epidemiology and Aging Research, Heinrich Heine University Dusseldorf and Heinrich Heine University Dusseldorf
Downloads 120 (604,538)

Abstract:

Loading...

prostate cancer, MRI, PSA, MRI/US fusion biopsy, risk-adapted screening

2.

Establishing Medical Intelligence - Leveraging FHIR to Improve Clinical Management

Number of pages: 23 Posted: 30 Jun 2023
University of Duisburg-Essen - Institute for Artificial Intelligence in Medicine (IKIM), University of Duisburg-Essen - Institute for Artificial Intelligence in Medicine (IKIM), University of Duisburg-Essen - Institute for Artificial Intelligence in Medicine (IKIM), University of Duisburg-Essen - Institute for Artificial Intelligence in Medicine (IKIM), University of Duisburg-Essen - Institute for Artificial Intelligence in Medicine (IKIM), University of Duisburg-Essen - Institute for Artificial Intelligence in Medicine (IKIM), University of Duisburg-Essen - Institute for Artificial Intelligence in Medicine (IKIM), University of Duisburg-Essen - Center for Translational Neuro- and Behavioral Sciences, University of Duisburg-Essen - Center for Translational Neuro- and Behavioral Sciences, University of Duisburg-Essen - Department of Cardiology and Vascular Medicine, University of Duisburg-Essen - Department of Cardiology and Vascular Medicine, University Hospital Essen - Department of Urology, University of Duisburg-Essen - Department of Urology, University of Duisburg-Essen - Department of Nuclear Medicine, University of Duisburg-Essen - Department of Endocrinology, Diabetes and Metabolism, University of Duisburg-Essen - Institute of Medical Microbiology, University of Duisburg-Essen - Department of Anaesthesiology and Intensive Care Medicine, Department of Hematology and Stem Cell Transplantation, University of Duisburg-Essen, University of Duisburg-Essen - Institute for Artificial Intelligence in Medicine (IKIM), Heidelberg University - Faculty of Mathematics and Computer Science, University of Duisburg-Essen - Institute for Artificial Intelligence in Medicine (IKIM) and University of Duisburg-Essen - Institute for Artificial Intelligence in Medicine (IKIM)
Downloads 114 (621,896)

Abstract:

Loading...

Medical Intelligence, Big Data, Real World Evidence, Machine learning, FHIR, Prostate Cancer, Sepsis, Myocardial Infarction, Stroke, Diabetes

3.

Development and Validation of Nomograms to Predict Outcome Following LuPSMA Radionuclide Treatment for Metastatic Castration-Resistant Prostate Cancer: A Multicenter International Study

Number of pages: 21 Posted: 05 Mar 2021
University of California, Los Angeles (UCLA) - Ahmanson Translational Theranostics Division, University of California, Los Angeles (UCLA) - Ahmanson Translational Theranostics Division, University of California, Los Angeles (UCLA) - Department of Medicine Statistics Core, University of California, Los Angeles (UCLA) - Ahmanson Translational Theranostics Division, University Hospital Essen - Department of Urology, Technische Universität München (TUM) - Department of Nuclear Medicine, University of Duisburg-Essen - Department of Nuclear Medicine, Peter MacCallum Cancer Centre, University Hospital Heidelberg - Department of Nuclear Medicine, Excel Diagnostics and Nuclear Oncology Center, Technische Universität München (TUM) - Department of Urology, University Hospital Heidelberg - Department of Nuclear Medicine, University of California, Los Angeles (UCLA) - Ahmanson Translational Theranostics Division, Technische Universität München (TUM) - Department of Nuclear Medicine, University of California, Los Angeles (UCLA) - Ahmanson Translational Theranostics Division, Technische Universität München (TUM) - Department of Nuclear Medicine, UCLA Medical Center - Department of Urology, Excel Diagnostics and Nuclear Oncology Center, Heidelberg University - Department of Nuclear Medicine, University of California, Los Angeles (UCLA) - Department of Medicine Statistics Core, University of Duisburg-Essen - Department of Nuclear Medicine, University of California, Los Angeles (UCLA) - Department of Molecular and Medical Pharmacology (DMMP), Peter MacCallum Cancer Centre, University of Duisburg-Essen - Department of Nuclear Medicine and Technische Universität München (TUM) - Department of Nuclear Medicine
Downloads 43 (1,145,425)
Citation 3

Abstract:

Loading...